Protect effect of Intermedin1-53 on isoproterenol-induced ischemic injury in rats heart

Chinese Pharmacological Bulletin

Volumn 21, Issue 12, 2005, Pages 1454-1459

  Jia, Yue Xia ^a   Pan, Chun Shui ^b   Geng, Bin ^b   Yang, Jing Hui ^b   Zhao, Jing ^b   Yu, Fang ^b   Helen, Gerns ^d   Ou Yang, Ming ^d   Yang, Jun ^d   Tang, Chao Shu ^b,c   Qi, Yong Fen ^b,c  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d PHOENIX PHARMACEUTICALS INC   (United States)

Author keywords

Calcitonin receptor like receptor; cAMP; Intermedin; Isoproterenol; Receptor activity modifying protein

Indexed keywords

CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; INTERMEDIN; INTERMEDIN RECEPTOR; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; RECEPTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 32344431688     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Roh J, Chang CL, Bhalla A et al. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J]. J Biol Chem, 2004, 279(8):7264-74.
2. 1-53 on cardiac function and ischemia/reperfusion injury in isolated rat hearts[J]. Biochemical Biophysical Research Communications, 2005, 327:713-9.
3. Rona G, Chappel CI, Balzas T et al. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat[J]. Pathol, 1959, 67:443-55.
4. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction[J]. Anal Biochem, 1979, 95:351-58.
5. Qi YF, Bu DF, da Niu D et al. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene[J]. Peptides, 2002, 23(6):1141-7.
6. Wolff AA, Hines DK, Karliner J S. Refined membrane prepa 2 rations mask ischemic fall in myocardial beta-receptor density[J]. Am J Physiol, 1989, 257(3pt2):H1032-6.
7. Schwartz A. Methods in pharmacology[M]. vol 5. New york: Plenum Publishing Corporation, 1984:1-12.
8. Takei Y, Inoue K, Ogoshi M et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator[J]. FEBS Lett, 2004, 556(1-3):53-8.
9. Nishikimi T, Yoshihara F, Mori Y et al. Cardioprotective effect of adrenomedullin in heart failure[J]. Hypertens Res, 2003, 26 Suppl: S121-7.
10. Niu P, Shindo T, Iwata H et al. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage [J]. Circulation, 2004, 109(14):1789-94.
11. Franco-Cereceda A, Liska J. Potential of calcitonin gene-related peptidein coronary heart disease[J]. Pharmacology, 2000, 60 (1):1-8.
12. Grimm D, Elsner D, Schunkert H et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system[J]. Cardiovasc Res, 1998; 37:91-100.
13. Kuwasako K, Cao YN, Nagoshi Y et al. Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins[J]. Mol Pharmacol, 2004, 65(1):207-13.
14. Shimosawa T, Shibagaki Y, Ishibashi K et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage[J]. Circulation, 2002, 105:1062-111.
15. Ren YS, Ma TG, Wang HB et al. Membrane fluidity changes in myocardial cells following sever hypoxia and simulated reperfusion and effects of calcitonin gene-related peptide[J]. Med Sci Res, 1993, 21(17):627-8.